| Income Statement | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 838 | 834 | 1,253 | 732 |
| Net loss | -8,965 | -9,354 | -7,357 | -5,059 |
| Unrealized foreign currency translation gain (loss) | 89 | - | - | - |
| Total other comprehensive income (loss) | 89 | - | - | - |
| Total comprehensive loss | -8,876 | - | - | - |
| Earnings per share, basic | -0.22 | -0.24 | -0.33 | -0.48 |
| Earnings per share, diluted | -0.22 | -0.24 | -0.33 | -0.48 |
| Weighted average number of shares outstanding, basic | 41,521,280 | 38,599,453 | 22,075,332 | 10,644,533 |
| Weighted average number of shares outstanding, diluted | 41,521,280 | 38,599,453 | 22,075,332 | 10,644,533 |
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)